Epilepsy affects 1% of the general population and 3% of the elderly. Patients with epilepsy face great challenges: limited driving privileges, less opportunities for employment, and high rates of anxiety and depression. Even today, some patients and families believe epilepsy leads to mental retardation. New research studies have shown that patients with uncontrolled seizures have an alarmingly high lifetime risk of sudden unexpected death.
Fullerton Neurology and Headache Center is experienced in diagnosing and treating all types of seizures. A new generation of medications is more effective and better tolerated. Our goal is “zero tolerance” for seizures and medication side effects.
As the population ages, Alzheimer has reached epidemic proportions. Incredibly, it affects up to 50% of people 85 years and older. If we live long enough, will we all develop dementia? Hundreds of billions of dollars of our health care resources go to the care of Alzheimer disease patients.
We at Fullerton Neurology and Headache Center assist patients with memory disorders. It is critical to determine which complaints are normal for age and which are precursors of Alzheimer disease. Newer therapies are more effective with early diagnosis. Recent research has also shed light on preventative measures, which include reducing risk factors, lifestyle changes, medications and supplements. We are also actively involved in clinical trials. Our newest Alzheimer’s clinical trials involve monoclonal antibodies that target both amyloid and tau.
Parkinson disease affects 1% of the population over age 65, but is increasingly recognized in younger patients as well. Current research targets effective treatment of symptoms, approaches to limit progression, and imaging methods that lead to an earlier and more confident diagnosis. Deep brain stimulation is very effective for some patients, and the techniques are continuously being refined.
Parkinson disease challenging to live with and to treat. Our goal is to help patients maintain independence and a good quality of life.
Stroke is the third leading cause of death in the United States after heart disease and cancer. Primary and secondary prevention of stroke is critical and has been proven to reduce risks and improve outcomes. New “clot busters” hold great promise.
Fullerton Neurology and Headache Center can help patients address risk factors and recognize the warning signs. We are committed to assisting stroke patients with recovery and prevention of another stroke.
There are now 4 botulinum toxin preparations available to patients. Each has its place. We have expertise in using them for the following conditions:
-Cervical dystonia (torticollis, “wry neck”)
-Spasticity (caused by stroke, MS, traumatic brain injury)
-Blepharospasm (excessive blinking)
-Hemifacial spasm (facial muscle spasms)
Before botulinum toxin was available, there was limited success in treating these disorders. These injections have improved the quality of life for many patients and are covered by most health insurance plans.
Fullerton Neurology and Headache Center can help evaluate and treat these and other neurological symptoms. Typically, primary care physicians refer patients for consultations, but patients may seek care directly.